Werewolf Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.

CEO

Daniel J. Hicklin

CEODaniel J. Hicklin

Employees

Employees46

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2017

Founded2017

Employees

Employees46

HOWL Key Statistics

Market cap

32.39M

Market cap32.39M

Price-Earnings ratio

-0.44

Price-Earnings ratio-0.44

Dividend yield

—

Dividend yield—

Average volume

303.28K

Average volume303.28K

High today

$0.7235

High today$0.7235

Low today

$0.6402

Low today$0.6402

Open price

$0.6569

Open price$0.6569

Volume

131.72K

Volume131.72K

52 Week high

$6.89

52 Week high$6.89

52 Week low

$0.595

52 Week low$0.595

Werewolf Therapeutics

Why Robinhood?

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. Show more

HOWL Key Statistics

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.